(Q35782888)

10 August 2017

1 reference

title

Receptor protein tyrosine phosphatase zeta as a therapeutic target for glioblastoma therapy (English)

1 reference

10 August 2017

1 reference

Sabine Müller

1 reference

10 August 2017

Katrin Lamszus

1 reference

10 August 2017

Karoly Nikolich

series ordinal

1 reference

10 August 2017

Manfred Westphal

series ordinal

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

Expert Opinion on Therapeutic Targets

10 August 2017

published in

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

10 August 2017

page(s)

211-220

1 reference

10 August 2017

cites work

Cancer statistics, 1994.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Phenotype vs genotype in the evolution of astrocytic brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

An antisense EGFR oligodeoxynucleotide enveloped in Lipofectin induces growth inhibition in human malignant gliomas in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Release of regulators of angiogenesis following Hypocrellin-A and -B photodynamic therapy of human brain tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Glioma invasion in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

A functional p53-responsive intronic promoter is contained within the humanmdm2gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

A human transmembrane protein-tyrosine-phosphatase, PTP zeta, is expressed in brain and has an N-terminal receptor domain homologous to carbonic anhydrases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Demonstration that the leukocyte common antigen CD45 is a protein tyrosine phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Structural and evolutionary relationships among protein tyrosine phosphatase domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Receptor protein tyrosine phosphatases in nervous system development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Purification, characterization and developmental expression of a brain-specific chondroitin sulfate proteoglycan, 6B4 proteoglycan/phosphacan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Interactions of the chondroitin sulfate proteoglycan phosphacan, the extracellular domain of a receptor-type protein tyrosine phosphatase, with neurons, glia, and neural cell adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Involvement of receptor-like protein tyrosine phosphatase zeta/RPTPbeta and its ligand pleiotrophin/heparin-binding growth-associated molecule (HB-GAM) in neuronal migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Phosphacan Short Isoform, a Novel Non-proteoglycan Variant of Phosphacan/Receptor Protein Tyrosine Phosphatase-β, Interacts with Neuronal Receptors and Promotes Neurite Outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

No obvious abnormality in mice deficient in receptor protein tyrosine phosphatase beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

A critical role for the protein tyrosine phosphatase receptor type Z in functional recovery from demyelinating lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Regulated expression during development and following sciatic nerve injury of mRNAs encoding the receptor tyrosine phosphatase HPTPzeta/RPTPbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Phosphacan, a chondroitin sulfate proteoglycan of brain that interacts with neurons and neural cell-adhesion molecules, is an extracellular variant of a receptor-type protein tyrosine phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

High affinity binding and overlapping localization of neurocan and phosphacan/protein-tyrosine phosphatase-zeta/beta with tenascin-R, amphoterin, and the heparin-binding growth-associated molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Glial tumor cell adhesion is mediated by binding of the FNIII domain of receptor protein tyrosine phosphatase beta (RPTPbeta) to tenascin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

The core protein of the chondroitin sulfate proteoglycan phosphacan is a high-affinity ligand of fibroblast growth factor-2 and potentiates its mitogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

The carbonic anhydrase domain of receptor tyrosine phosphatase beta is a functional ligand for the axonal cell recognition molecule contactin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Identification of GIT1/Cat-1 as a substrate molecule of protein tyrosine phosphatase zeta /beta by the yeast substrate-trapping system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Protein tyrosine phosphatase zeta/RPTPbeta interacts with PSD-95/SAP90 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

A sodium channel signaling complex: modulation by associated receptor protein tyrosine phosphatase beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Structural basis for inhibition of receptor protein-tyrosine phosphatase-alpha by dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

A novel 17 kD heparin-binding growth factor (HBGF-8) in bovine uterus: purification and N-terminal amino acid sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Localization of pleiotrophin and its mRNA in subpopulations of neurons and their corresponding axonal tracts suggests important roles in neural-glial interactions during development and in maturity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

A role for receptor tyrosine phosphatase zeta in glioma cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Hyperthermia in combined treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Recombinant immunotoxins specific for a mutant epidermal growth factor receptor: targeting with a single chain antibody variable domain isolated by phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Chimeric anti-tenascin antibody 81C6: increased tumor localization compared with its murine parent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

Phase II trial of gefitinib in recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.211

21 January 2018

Identifiers

DOI

10.1517/14728222.8.3.211

1 reference

release_uxfzv72tovd4nov26l3vmfumeu

10 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uxfzv72tovd4nov26l3vmfumeu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference